Monday, October 6, 2008

The answer for skin cancer

Curaderm BEC5 In The News:

Curaderm BEC5 on TV News

ORDER SECURELY ONLINE
or learn more:

The History of Curaderm
Curaderm BEC5 - United Kingdom Hospitals Dermatologist Clinical Trial
Curaderm - BEC5 for Sunspots and Keratosis
Curaderm BEC5 Usage

The answer for skin cancer

BEC5 / Curaderm contains a specially purified plant extract from the Solanum Sodomaeum, the so-called Devil's apple- which is found in the Australasia region. The extract, known as Solasodine Glycosides, (0.005%) is also found in smaller quantities in the eggplant and aubergine.

After two decades of research and clinical trials, biochemist, Dr. Bill E. Cham, has discovered that BEC5 when applied topically can eradicate non-melanoma skin cancers, specifically:

  • Basal cell carcinomas (BCC).
  • Squamous cell carcinomas (SCC).

BEC5 cream has also been shown to be efficacious with benign tumours, including:

  • Keratoses.
  • Keratoacanthomas.
  • Sun spots.
  • Age spots.

Numerous clinical trials in Australia and Great Britain have confirmed BEC5's ability to regress non-melanoma skin cancers. In one open study with 72 patients, treatment with BEC5 cream resulted in the regression of all treated lesions (56 actinic keratoses, 39 BCCs and 29 SCCs), with 100% healed after 1 to 13 weeks of treatment.

Recent trials in 10 UK hospitals found that a twice daily topical application of BEC5 cream to the affected areas gave a complete remission to 78% of the patients within 8-weeks. The remaining 22% of patients had also improved and needed longer treatment times, all this was made possible without chemotherapy, radiotherapy or surgery.

The dermatologists at the Royal London Hospital concluded that: "BEC5 is a topical preparation which is safe and effective, an ideal therapy for outpatient treatment... It is a cost effective treatment for both primary and secondary skin cancer care."

Furthermore, the histological analyses of biopsies taken before, during and after treatment give compelling evidence of the continuing efficacy of BEC5 because treated skin cancer lesions have not recurred for at least 5 years after cessation of therapy.

The figure above shows A) The clinical diagnosis of a BCC on the nose of a patient before treatment with BEC5 - B) During therapy and C) the site of the treated BCC after completion of therapy.

The figure above shows a large BCC on the temple. This BCC had been surgically removed and skin grafts applied on two previous occasions, only to return. Just four weeks treatment with BEC5 resulted in full regression and no recurrence after 5-years. Note the cosmetic result.

BEC5 cream is therefore recommended to be used to treat areas of the skin that may have become discoloured, thickened or scaly as a result of exposure to sun (UV) light. These areas of the skin are known as keratoses. BEC5 cream is effective to treat true malignant skin cancers such as the non-melanoma basal cell carcinoma and squamous cell carcinoma. To date, it is estimated that more than 80,000 people have used BEC5 and shown below are just some of the results achieved with BEC5 cream:

BEC5 works because it contains a plant sugar called rhamnose, (which is not usually found in mammalian species). Specific endogenous lectins, (which are receptors for the sugar part of the glycoalkaloids) are present in the plasma membranes of susceptible cancer cells, but they not present in normal cells. Therefore BEC5 recognizes and binds the sugar rhamnose of the glycoalkaloid to the cancer cell. Subsequently, this enters the cancer cell and causes cell death by destroying the lysosome.

Side effects to date have been limited to skin reddening, although during treatment erosion, ulceration and shedding of unwanted skin cells is also likely to take place.

Clean the area to be treated with a mild antiseptic (to remove old skin cells). BEC5 should be applied relatively thickly to the area at least twice daily and a micro pore placed over the area. The eyes should be avoided. If any excess occurs, wash and wipe away with cold water. Application should continue for a minimum of 7 days and a maximum of 60 days, this time dependant upon the size, need and regularity of application.

BEC5 should not be applied to moles and melanomas. Furthermore, BEC5 should not be used by persons who are allergic to eggplant or aspirin. For full details please see the approved use leaflet below.

A 20 ml. bottle of BEC5 can provide enough material to treat one large skin cancer, two medium sized ones, six small ones or twelve sun spots.

Apart from the need to "treat" cancer, BEC5's efficacy to help remove and protect against sun spots represents a major step forward in the prevention and "control" of skin cancers. Its ease of use, cost effectiveness, proven efficacy and safety all represent a very significant breakthrough for majority of skin carcinomas, which are by far the most common forms of cancer.



What our customers say...

I have good news to report. After one month of applying BEC5 twice a day, the lesion is now 50% covered with new tissue. It took me a while to be able to distinguish the new from the old eschar which needed debridement. I had the help of a retired doctor for this. It still burns when I apply it but I can deal with that.

For the record the original dime-sized lesion grew to a scarry-looking large quarter size of raw flesh before it started to heal. I did use Neosporin twice for 4 hours only when it was oozing yellow. And I had difficulty keeping it moist when it reached as far as my hairline. But I found that as long as it was totally covered by the Micropore, it was OK.

You may pass this on to other intrepid first-time users along with my phone number. It is good to have someone to ask questions of.

Thank you so much for encouraging me to do this. It is by far the best approach we have to healing squamous cell carcinoma and keratoses.

Marie
Santa Barbara

No comments: